AI could speed up finding the right patients for cancer trials
NCT ID NCT06561230
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an AI tool can help doctors quickly and fairly identify prostate cancer patients who might qualify for a clinical trial. Researchers will use AI to rank patient records by how well they match trial criteria, then check the results. The goal is to see if this human-plus-AI approach is more efficient and inclusive than traditional methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could make it quicker and fairer to find patients for cancer trials, helping research move faster.
- What could go wrong
- This is an early-stage study testing a tool, not a treatment. It may not work better than current methods or may miss some patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?